Emran Esmaeilzadeh1, Mostafa Saghi1, Mehdi Hassani1, Saeideh Davar2, Behrang Alani3, Bahram Pakzad4, Sepideh Ghobakhloo5, Sharifeh Khosravi5, Mehrdad Nasrollahzadeh Sabet6. 1. School of Medicine, AJA University of Medical Science, Tehran, Iran. 2. Department of Epidemiology and Biostatistics, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. 3. Department of Applied Cell Sciences, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran. 4. Division of Rheumatology, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran. 5. Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non Communicable Disease, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. 6. School of Medicine, AJA University of Medical Science, Tehran, Iran. M.nasrollahzadehs@yahoo.com.
Abstract
INTRODUCTION/ OBJECTIVES: Systemic lupus erythematosus (SLE) is a multifactorial systemic autoimmune disease, in which genetic susceptibility plays a pivotal role. The nucleotide oligomerization domain 2 (NOD2) gene is one of the main regulators of chronic inflammatory conditions and could be involved in SLE pathogenesis. Single nucleotide polymorphisms (SNPs) in miRNA binding sites which are located in 3'UTR of the NOD2 gene could be associated with SLE risk by dysregulation of NOD2 expression. In the present study, we assessed the possible association between SNPs rs3135500 and rs3135499 in the NOD2 gene with SLE risk in the Iranian population. METHODS: A case-control study using 110 SLE patients and 120 control subjects was undertaken to estimate rs3135500 (G > A) and rs3135499 (A > C) genotypes via real-time PCR high-resolution melting method (HRM). RESULTS: No significant association was observed between allele and genotype frequencies of rs3135500 and rs3135499 polymorphisms and SLE risk in this population (P > 0.05). However, there was an obvious association between rs3135500 (A allele) with laboratory factors that are associated with disease activity (P < 0.05) and some clinical manifestations that are associated with disease severity such as neurological symptoms, skin manifestations, renal involvements, and higher serum concentration of creatinine (P < 0.05). Besides, rs3135499 (C allele) was correlated with renal involvement and also the concentration of creatinine (P < 0.05). Moreover, in the patients group, the risk alleles in these polymorphisms were associated with lower age of onset (P < 0.05). CONCLUSIONS: Our results suggest a substantial association between NOD2 polymorphisms with clinicopathological characteristics and SLE disease activity. Key Points • Single nucleotide polymorphisms (SNPs) in miRNA binding sites which are located in 3'UTR of the NOD2 gene could be associated with SLE risk by dysregulation of NOD2 expression. • Our results suggested that two miRSNPs (rs3135500 and rs3135499) in the NOD2 gene were meaningfully correlated with clinicopathological characteristics and disease activity of SLE.
INTRODUCTION/ OBJECTIVES: Systemic lupus erythematosus (SLE) is a multifactorial systemic autoimmune disease, in which genetic susceptibility plays a pivotal role. The nucleotide oligomerization domain 2 (NOD2) gene is one of the main regulators of chronic inflammatory conditions and could be involved in SLE pathogenesis. Single nucleotide polymorphisms (SNPs) in miRNA binding sites which are located in 3'UTR of the NOD2 gene could be associated with SLE risk by dysregulation of NOD2 expression. In the present study, we assessed the possible association between SNPs rs3135500 and rs3135499 in the NOD2 gene with SLE risk in the Iranian population. METHODS: A case-control study using 110 SLE patients and 120 control subjects was undertaken to estimate rs3135500 (G > A) and rs3135499 (A > C) genotypes via real-time PCR high-resolution melting method (HRM). RESULTS: No significant association was observed between allele and genotype frequencies of rs3135500 and rs3135499 polymorphisms and SLE risk in this population (P > 0.05). However, there was an obvious association between rs3135500 (A allele) with laboratory factors that are associated with disease activity (P < 0.05) and some clinical manifestations that are associated with disease severity such as neurological symptoms, skin manifestations, renal involvements, and higher serum concentration of creatinine (P < 0.05). Besides, rs3135499 (C allele) was correlated with renal involvement and also the concentration of creatinine (P < 0.05). Moreover, in the patients group, the risk alleles in these polymorphisms were associated with lower age of onset (P < 0.05). CONCLUSIONS: Our results suggest a substantial association between NOD2 polymorphisms with clinicopathological characteristics and SLE disease activity. Key Points • Single nucleotide polymorphisms (SNPs) in miRNA binding sites which are located in 3'UTR of the NOD2 gene could be associated with SLE risk by dysregulation of NOD2 expression. • Our results suggested that two miRSNPs (rs3135500 and rs3135499) in the NOD2 gene were meaningfully correlated with clinicopathological characteristics and disease activity of SLE.
Authors: Arvind Kaul; Caroline Gordon; Mary K Crow; Zahi Touma; Murray B Urowitz; Ronald van Vollenhoven; Guillermo Ruiz-Irastorza; Graham Hughes Journal: Nat Rev Dis Primers Date: 2016-06-16 Impact factor: 52.329
Authors: Antonio Julià; Francisco Javier López-Longo; José J Pérez Venegas; Silvia Bonàs-Guarch; Àlex Olivé; José Luís Andreu; Mª Ángeles Aguirre-Zamorano; Paloma Vela; Joan M Nolla; José Luís Marenco de la Fuente; Antonio Zea; José María Pego-Reigosa; Mercedes Freire; Elvira Díez; Esther Rodríguez-Almaraz; Patricia Carreira; Ricardo Blanco; Víctor Martínez Taboada; María López-Lasanta; Mireia López Corbeto; Josep M Mercader; David Torrents; Devin Absher; Sara Marsal; Antonio Fernández-Nebro Journal: Arthritis Res Ther Date: 2018-05-30 Impact factor: 5.156
Authors: Chun Su; Matthew E Johnson; Annabel Torres; Rajan M Thomas; Elisabetta Manduchi; Prabhat Sharma; Parul Mehra; Carole Le Coz; Michelle E Leonard; Sumei Lu; Kenyaita M Hodge; Alessandra Chesi; James Pippin; Neil Romberg; Struan F A Grant; Andrew D Wells Journal: Nat Commun Date: 2020-07-03 Impact factor: 14.919